HuGE Literature Finder
Records 1-17
|
No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV-1-Infected Subjects.
Journal of clinical pharmacology 2019 Jan 59 (1): 139-152. Vourvahis Manoli, McFadyen Lynn, Nepal Sunil, Valluri Srinivas Rao, Fang Annie, Fate Gwendolyn D, Wood Linda S, Marshall Jean-Claude, Chan Phylinda L S, Nedderman Angus, Haynes Julian, Savage Mark E, Clark Andrew, Smith Kimberly Y, Heera Jayva |
|
Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.
Malaria journal 2017 07 16 (1): 267. Mutagonda Ritah F, Kamuhabwa Appolinary A R, Minzi Omary M S, Massawe Siriel N, Asghar Muhammad, Homann Manijeh V, Färnert Anna, Aklillu Ele |
|
The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome.
Malaria journal 2017 09 16 (1): 383. Kiaco Kinanga, Rodrigues António Sebastião, do Rosário Virgílio, Gil José Pedro, Lopes Dino |
|
The effect of SNPs in CYP450 in chloroquine/primaquine Plasmodium vivax malaria treatment.
Pharmacogenomics 2016 Oct . Sortica Vinicius A, Lindenau Juliana D, Cunha Maristela G, Ohnishi Maria DO, Ventura Ana Maria R, Ribeiro-Dos-Santos Ândrea Kc, Santos Sidney Eb, Guimarães Luciano Sp, Hutz Mara |
|
Influence of CYP3A5 genotypes on tacrolimus dose requirement: age and its pharmacological interaction with ABCB1 genetics in the Chinese paediatric liver transplantation.
International journal of clinical practice 2015 May 69 Suppl 183 53-62. Yang T-H, Chen Y-K, Xue F, Han L-Z, Shen C-H, Zhou T, Luo Y, Zhang J-J, Xia |
|
Benefits of minimizing immunosuppressive dosage according to cytochrome P450 3A5 genotype in liver transplant patients: findings from a single-center study.
Genetics and molecular research : GMR 2015 14 (2): 3191-9. Wang L, Li N, Wang M X, Lu S |
|
Functional CYP2B6 variants and virologic response to an efavirenz-containing regimen in Port-au-Prince, Haiti.
The Journal of antimicrobial chemotherapy 2014 Aug 69 (8): 2187-90. Haas David W, Severe Patrice, Jean Juste Marc Antoine, Pape Jean William, Fitzgerald Daniel |
|
Influence of cytochrome P450 3A5 polymorphisms on viral infection incidence in kidney transplant patients treated with tacrolimus.
Transplantation proceedings 2014 46 (2): 570-3. Hattori Y, Tanaka H, Teranishi J, Ishida H, Makiyama K, Miyajima E, Noguchi K, Kubota |
|
Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study.
European journal of clinical pharmacology 2013 Nov 69 (11): 1909-16. Ciccacci Cinzia, Di Fusco Davide, Marazzi Maria C, Zimba Ines, Erba Fulvio, Novelli Giuseppe, Palombi Leonardo, Borgiani Paola, Liotta Giusep |
|
Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients.
Annals of transplantation : quarterly of the Polish Transplantation Society 2013 18 349-57. Mizuno Shugo, Nakatani Kaname, Muraki Yuichi, Tanemura Akihiro, Azumi Yoshinori, Kuriyama Naohisa, Ohsawa Ichiro, Kishiwada Masashi, Usui Masanobu, Sakurai Hiroyuki, Tabata Masami, Okuda Masahiro, Nobori Tsutomu, Isaji Shu |
|
Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity.
Clinical & developmental immunology 2013 2013 982163. Mizuno Shugo, Muraki Yuichi, Nakatani Kaname, Tanemura Akihiro, Kuriyama Naohisa, Ohsawa Ichiro, Azumi Yoshinori, Kishiwada Masashi, Usui Masanobu, Sakurai Hiroyuki, Tabata Masami, Yamamoto Norihiko, Yamada Tomomi, Shiraki Katsuya, Takei Yoshiyuki, Nobori Tsutomu, Okuda Masahiro, Isaji Shu |
|
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.
BMC infectious diseases 2013 13 261. Mukonzo Jackson K, Okwera Alphonse, Nakasujja Neoline, Luzze Henry, Sebuwufu Deogratious, Ogwal-Okeng Jasper, Waako Paul, Gustafsson Lars L, Aklillu Ele |
|
Renal function and genetic polymorphisms in pediatric heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2012 Jul . Feingold B, Brooks MM, Zeevi A, Ohmann EL, Burckart GJ, Ferrell RE, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Naftel DC, Webber SA |
|
Functional polymorphisms in CYP2C19 & CYP3A5 genes associated with decreased susceptibility for paediatric tuberculosis.
The Indian journal of medical research 2012 May 135 (5): 642-9. Feng Wei-Xing, Liu Fang, Gu Yi, Jiao Wei-Wei, Sun Lin, Xiao Jing, Wu Xi-Rong, Miao Qing, Shen Chen, Shen Dan, Shen Ado |
|
Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
Transplantation proceedings 2012 Jan 44 (1): 109-14. Cho J-H, Yoon Y-D, Park J-Y, Song E-J, Choi J-Y, Yoon S-H, Park S-H, Kim Y-L, Kim C |
|
Influencing factors for cure of clonorchiasis by praziquantel therapy: infection burden and CYP3A5 gene polymorphism.
The Korean journal of parasitology 2011 Mar 49 (1): 45-9. Kim Chung Hyeon, Lee Jeong-Keun, Chung Byung-Suk, Li Shunyu, Choi Min-Ho, Hong Sung-T |
|
Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique.
Pharmacogenomics 2010 Jan 11 (1): 23-31. Ciccacci Cinzia, Borgiani Paola, Ceffa Susanna, Sirianni Elisabetta, Marazzi Maria C, Altan Anna M Doro, Paturzo Giovanna, Bramanti Placido, Novelli Giuseppe, Palombi Leonar |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: